Term sheet basics every first-time founder should actually understand

A term sheet is short, often just two or three pages, which creates a false sense that it's simple. A handful of those lines matter far more than their brevity suggests, and understanding them before you're sitting across from a lawyer under time pressure changes how confidently you can negotiate.

Valuation and the cap. The headline number gets most of the attention in conversation, but the valuation cap (for a SAFE) or the pre-money valuation (for a priced equity round) is what actually determines how much of the company you're giving up for this specific check. Compare it against your last round's cap or valuation, not just against the dollar amount being raised in isolation, since a "higher" valuation paired with a much larger raise can still mean more dilution than a lower valuation with a smaller check.

Liquidation preference. This clause determines who gets paid first, and how much, if the company is ever sold, and for what amount. A standard 1x non-participating preference is considered founder-friendly and market-standard in most healthy deals: the investor gets their money back first in a sale, then everyone shares the remaining proceeds by ownership percentage. Anything beyond that, a higher multiple like 1.5x or 2x, or a participating preference where the investor gets their money back and then still shares in the remaining proceeds, meaningfully changes the economics of an eventual exit in ways that often aren't obvious just from glancing at the number. This is one of the clauses most worth a real lawyer's attention rather than a quick read-through.

Board composition. Who gets a board seat, and how many seats each side holds, shapes control of the company for years, not just for the life of this specific round. A board seat is a standing, ongoing vote on major decisions, future fundraising approval, executive hiring and firing, significant new debt or equity, not a symbolic gesture extended as a courtesy. Pay attention not just to whether an investor gets a seat, but to the overall board composition once this round closes, including how many independent seats exist and who controls them.

Pro-rata rights. These rights let an investor maintain their existing ownership percentage by participating in future rounds proportionally. This is common and generally reasonable, but it's worth understanding because it affects how much allocation is left available for new investors in your next round, and can occasionally complicate that next round's dynamics if several existing investors all exercise pro-rata simultaneously.

Anti-dilution protection. This clause protects existing investors if a future round happens at a lower valuation than this one, a down round. Broad-based weighted average anti-dilution is the standard, relatively founder-friendly version, adjusting the existing investor's effective price modestly in a down-round scenario. Full ratchet anti-dilution is far more aggressive, effectively repricing the existing investor's entire stake to match the new, lower price, which can be severely punitive to founders and existing employees in a down round. Seeing full ratchet language in a term sheet is worth flagging to a lawyer immediately rather than treating as boilerplate.

Information and protective rights. Beyond the headline terms, most term sheets include a list of decisions that require investor consent beyond normal board approval, sometimes called protective provisions. These can range from reasonable (approval for major asset sales) to restrictive (approval required for routine hiring decisions above a certain level). Reading this list carefully matters more than founders expect, since it defines the actual day-to-day autonomy you'll have running the company after the round closes.

None of this replaces an actual lawyer reviewing your specific term sheet in your specific jurisdiction. But knowing which clauses deserve real scrutiny, versus which are genuinely standard and low-risk, changes how you spend that legal review time, and how confidently you can push back on the terms that actually matter instead of getting lost in the ones that don't.

One more clause worth knowing: the no-shop or exclusivity period. Most term sheets include a window, commonly 30-60 days, during which you agree not to solicit or negotiate with other investors while this deal is being finalized. This is standard and generally reasonable, but it means accepting a term sheet effectively pauses your other fundraising conversations for that window, so it's worth being reasonably confident the deal will actually close before agreeing to a long exclusivity period with an investor who hasn't yet fully committed.

Drag-along and tag-along rights, briefly. Drag-along provisions let majority shareholders force minority shareholders to join a sale on the same terms, which protects a clean exit process but can override individual founder or early-investor preferences in an acquisition. Tag-along rights work in the founder's favor, letting minority holders join a sale on the same terms majority holders negotiate. Both are fairly standard, but worth knowing which one protects you and which one could bind you before an acquisition conversation is already underway.